T1	Intervention 48 111	propionyl-L-carnitine in patients with congestive heart failure
T2	Intervention 147 200	propionyl-L-carnitine (CAS 17298-37-2) versus placebo
T3	Intervention 553 660	500 mg of propionyl-L-carnitine was orally administered, 3 times a day in addition to their usual treatment
T4	Intervention 973 994	propionyl-L-carnitine
T5	Intervention 1012 1025	control group
T6	Intervention 1424 1445	propionyl-L-carnitine
